Meet the team: Leo James, Co-founder and Chief Scientific Adviser, TRIMTECH Therapeutics

17 February 2026 – Read news


TRIMTECH Therapeutics wins ‘Seed Raise of the Year’ at the 2025 European Lifestars Awards

17 November 2025 – Read news


Meet the team: Andrea Testa, Senior Director of Chemistry

05 November 2025 – Read news


TRIMTECH Therapeutics wins ‘Start-up of the Year’ at the 2025 TPD & Induced Proximity Awards

17 November 2025 – Read news


TRIMTECH Therapeutics featured in Clarivate’s report highlighting six companies advancing targeted protein degradation

07 October 2025 – Read news


Introducing Fierce Biotech’s 2025 Fierce 15

22 September 2025, Fierce Biotech – Read news


Nicki Thompson interview with Drug Discovery World

8 July 2025, Drug Disovery World – Read news


Academic co-founder, Leo James elected to Royal Society

20 May 2025, MRC Laboratory of Molecular Biology (LMB) website – Read news


Nicki Thompson, CEO talks with BiotechTV at BioTrinity 2025

02 April 2025, BiotechTV – Watch video


Lilly, Pfizer invest in UK startup’s seed round for neurodegeneration protein degraders

05 March 2025, Endpoints News – Read news

Nicki Thompson talks with BiotechTV at BioTrinity 2025

Nicki Thompson, TRIMTECH Therapeutics Limited’s CEO, gave an oral presentation at BioTrinity 2025.  In this post from BiotechTV she reviews the unique properties of TRIM21 that make it so powerful for selectively degrading protein aggregates while leaving soluble protein unaffected.